Back

Predictors, incidence, and clinical implications of arrhythmia following CAR-T therapy: a competing-risk analysis

30 August 2026 (08:15 - 08:45)
Organised by: Logo
Congress Presentation Part of: Early and late cardiovascular complications after haematological therapies Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Hemchandra Patel

Mayo Clinic Hospital-Rochester, Rochester (United States of America)

4 More presentations in this session

Presentation thumbnail
Incidence and predictors of cardiovascular adverse events after anthracycline-containing chemotherapy in lymphoma: a retrospective longitudinal cohort
Professor D. Zhao (Dalian, CN)
Abstract Slides Video
Presentation thumbnail
Long-term prognostic significance of cardiovascular complications following hematopoietic stem cell transplantation: a prospective regional cohort analysis
Associate Professor F. Guerra (Ancona, IT)
Abstract Slides Video
Presentation thumbnail
Product-dependent cardiac functional trajectories following CD19 CAR-T therapy in diffuse large B-cell lymphoma
Doctor I. Sunayama (Nishinomiya, JP)
Abstract Slides Video
Presentation thumbnail
Cardiovascular magnetic resonance characterisation of early myocardial changes following allogeneic hematopoietic stem cell transplantation and their clinical predictors
Doctor K. Chan (Melbourne, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Early and late cardiovascular complications after haematological therapies

The Event

Event poster

ESC Congress 2026

30 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular complications of chimeric antigen receptor (CAR)-t cell therapy: insights from a regional cardio-oncology program
21 June 2025
thumbnail
Congress Presentation
Beyond the first episode: predictors of NOAF recurrence after ICU stay
21 March 2026
thumbnail
Congress Presentation
Exploring arrhythmias in children, adolescents and young adults with cancer: the Rebuc study perspective.
20 June 2025
thumbnail
Congress Presentation
A new risk prediction model of adverse heart failure outcomes in arrhythmogenic right ventricular cardiomyopathy
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources